UNC Health is celebrating the addition of new technology to the hospital system in Chapel Hill, more than five years after efforts began to offer high-intensity focused ultrasounds.
Read more here.
UNC Health is celebrating the addition of new technology to the hospital system in Chapel Hill, more than five years after efforts began to offer high-intensity focused ultrasounds.
Read more here.
![[Biolojic in Business Wire] First Patient Dosed in Phase 2 Portion of Aulos Bioscience’s Phase 1/2 Clinical Trial for AU-007, a Computationally Designed IL-2 Antibody for Solid Tumor Cancers](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
